【24h】

Risk factors of mid-term mortality of patients with infective endocarditis.

机译:感染性心内膜炎患者中期死亡率的危险因素。

获取原文
获取原文并翻译 | 示例
       

摘要

In-hospital and long-term mortality of infective endocarditis (IE) are well noted, but the studies for mid-term (90-day) mortality of IE is still limited. We determine the mid-term mortality rate of IE and its significant predictors. Seventy patients with IE were hospitalised at St. Luke's International Hospital between January 1996 and March 2009, of whom 62 consecutive patients could be followed up for 90 days after diagnosis. We then calculated Kaplan-Meier (KM) estimates and performed time-to-event analysis. The mean (standard deviation, SD) age was 66.6 (15.3) years. Thirty-five patients (56%) were male. Blood cultures were positive in 87%. Causative microorganisms were: viridans group streptococci (23%), beta-streptococci (16%), Staphylococcus aureus (15%), including methicillin-resistant S. aureus (MRSA) (5%). Thirty-three cases (53%) had at least one complication such as heart failure (34%), central nervous system (CNS) complication (29%) or emboli peripheral to CNS (6%). KM estimates (95% CI) of the 90-day mortality was 14.5% (7.8-25%). In multiple regression analysis using the Cox proportional hazards model, hazard ratios of at least one complication for the 90-day mortality was 8.2 (1.4-155). Mid-term mortality of IE continues to be high and the presence of at least one complication may be considered as an independent risk factor of mid-term mortality.
机译:感染性心内膜炎(IE)的院内和长期死亡率已广为人知,但关于IE的中期(90天)死亡率的研究仍然有限。我们确定IE的中期死亡率及其重要预测指标。在1996年1月至2009年3月之间,有70例IE病人在圣卢克国际医院住院,确诊后90天内连续随访62例。然后,我们计算了Kaplan-Meier(KM)估计值并进行了事件发生时间分析。平均年龄(标准差,SD)为66.6(15.3)年。三十五名患者(56%)是男性。血培养阳性率为87%。致病微生物为:rid虫类链球菌(23%),β-链球菌(16%),金黄色葡萄球菌(15%),包括耐甲氧西林的金黄色葡萄球菌(MRSA)(5%)。 33例(53%)患有至少一种并发症,例如心力衰竭(34%),中枢神经系统(CNS)并发症(29%)或CNS周围的栓子(6%)。 90天死亡率的KM估计值(95%CI)为14.5%(7.8-25%)。在使用Cox比例风险模型进行的多元回归分析中,对于90天死亡率,至少一种并发症的风险比是8.2(1.4-155)。 IE的中期死亡率仍然很高,并且至少一种并发症的存在可以被认为是中期死亡率的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号